Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Bartoletti

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
Frontiers in Oncology|January 30, 2023
The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a <i>PIK3CA</i>-mutated endometrial cancerAnna Passarelli, Jole Ventriglia, Carmela Pisano, et al.
Critical Care (London, England)|June 14, 2022
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patientsMilo Gatti, Pier Giorgio Cojutti, Michele Bartoletti, et al.
Infection|September 1, 2023
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscapeAntonio Vena, Matteo Bassetti, Laura Mezzogori, et al.
Frontiers in Cellular and Infection Microbiology|July 16, 2021
The Gut Microbiota of Critically Ill Patients With COVID-19Paolo Gaibani, Federica D'Amico, Michele Bartoletti, et al.
Infection Control and Hospital Epidemiology|February 16, 2019
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: a prospective six-year experienceSara Tedeschi, Filippo Trapani, Annalisa Liverani, et al.
Ejhaem|October 17, 2022
Neutralizing monoclonal antibodies for early treatment of hospital-acquired SARS-CoV-2 infection in hematologic patientsLinda Bussini, Diletta Testi, Beatrice Tazza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2024
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19Andre C Kalil, Aastha Chandak, Luke S P Moore, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 20, 2025
Treatment of Stenotrophomonas malthophilia bloodstream infections from guidance to real life: multicenter retrospective cohort studyRenato Pascale, Angelo Maccaro, Mena Gallo, et al.
World Journal of Emergency Surgery : WJES|March 25, 2021
The role of procalcitonin in reducing antibiotics across the surgical pathwayMassimo Sartelli, Luca Ansaloni, Michele Bartoletti, et al.
Journal of Cancer Research and Clinical Oncology|July 26, 2018
Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncologyClaudia Bozza, Lorenzo Gerratana, Debora Basile, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
Frontiers in Oncology|January 30, 2023
The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a <i>PIK3CA</i>-mutated endometrial cancerAnna Passarelli, Jole Ventriglia, Carmela Pisano, et al.
Critical Care (London, England)|June 14, 2022
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patientsMilo Gatti, Pier Giorgio Cojutti, Michele Bartoletti, et al.
Infection|September 1, 2023
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscapeAntonio Vena, Matteo Bassetti, Laura Mezzogori, et al.
Frontiers in Cellular and Infection Microbiology|July 16, 2021
The Gut Microbiota of Critically Ill Patients With COVID-19Paolo Gaibani, Federica D'Amico, Michele Bartoletti, et al.
Infection Control and Hospital Epidemiology|February 16, 2019
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: a prospective six-year experienceSara Tedeschi, Filippo Trapani, Annalisa Liverani, et al.
Ejhaem|October 17, 2022
Neutralizing monoclonal antibodies for early treatment of hospital-acquired SARS-CoV-2 infection in hematologic patientsLinda Bussini, Diletta Testi, Beatrice Tazza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2024
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19Andre C Kalil, Aastha Chandak, Luke S P Moore, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 20, 2025
Treatment of Stenotrophomonas malthophilia bloodstream infections from guidance to real life: multicenter retrospective cohort studyRenato Pascale, Angelo Maccaro, Mena Gallo, et al.
World Journal of Emergency Surgery : WJES|March 25, 2021
The role of procalcitonin in reducing antibiotics across the surgical pathwayMassimo Sartelli, Luca Ansaloni, Michele Bartoletti, et al.
Journal of Cancer Research and Clinical Oncology|July 26, 2018
Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncologyClaudia Bozza, Lorenzo Gerratana, Debora Basile, et al.
Pageof 21